| (AUD) | Jun 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 324.21K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NSB.AX returned -64.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -40.9% |
| 1 year | -64.9% |
| 5 years | -80.9% |
| All-time high | $0.46 (Sep 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NSB.AX would be worth today ›No. NeuroScientific Biopharmaceuticals Limited has not paid a dividend in the past 12 months.
NeuroScientific Biopharmaceuticals Limited is part of the Healthcare sector.
NeuroScientific Biopharmaceuticals Limited has a market cap of 25.33M AUD, based on the latest quote.
